Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
The academy has secured partnerships with 15 esteemed hospitals
Glenmark released Picture Post Cards on World Vitiligo Day
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
        Subscribe To Our Newsletter & Stay Updated